Related Experiment Video

Updated: Jun 23, 2026

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

Cancer cell death by design: apoptosis, autophagy and glioma virotherapy

Matthew A Tyler1, Ilya V Ulasov, Maciej S Lesniak

  • 1The Brain Tumor Center, The University of Chicago, Chicago, IL 60637, USA.

Autophagy
|May 12, 2009
PubMed

Insights

Oncolytic adenoviruses kill malignant glioma cells. Research shows these viruses induce both autophagy and apoptosis, crucial findings for improving virotherapy strategies.

Area of Science:

  • Oncolytic virotherapy
  • Cancer research
  • Molecular cell biology

Background:

  • Autophagy is a known mechanism for oncolytic adenovirus-mediated cancer cell killing, particularly in malignant glioma.
  • Historically, adenovirus replication was primarily associated with inducing apoptosis (programmed cell death) in infected cells.

Purpose of the Study:

  • To investigate the mechanisms of cell death induced by conditionally replicating adenoviruses (CRAd) in malignant glioma models.
  • To differentiate between autophagy and apoptosis as the primary pathways of CRAd-induced cell death in glioma.

Main Methods:

  • Assessment of cell death mechanisms (autophagy and apoptosis) in malignant glioma models.
  • In vitro and in vivo studies using conditionally replicating adenoviruses (CRAd).

Main Results:

  • Initial in vitro studies indicated autophagy as the predominant mechanism of CRAd-induced cell death in glioma.
  • Further in vivo investigations revealed that CRAds can induce both apoptotic and autophagic cell death in malignant glioma.

Conclusions:

  • Conditionally replicating adenoviruses (CRAd) induce a dual cell death pathway (autophagy and apoptosis) in malignant glioma.
  • Understanding the interplay between autophagy and apoptosis is critical for optimizing oncolytic adenovirus vector design for glioma virotherapy.

More Related Videos

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Autophagic Cell Death01:18

Autophagic Cell Death

Christian de Duve discovered “autophagy,” a process in which cellular components are engulfed by membrane-bound organelles called autophagosomes. The autophagosomes then fuse with lysosomes to digest the enclosed contents. Autophagy is generally activated in cells to prevent cell death. However, cell death is triggered when the damage is beyond repair.
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and pro-apoptotic...
Overview of Cell Death01:30

Overview of Cell Death

Cell death is an essential process where the body gets rid of old or damaged cells. Cell proliferation and death need to be balanced, as an imbalance between the two may lead to cancer or autoimmune diseases.
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the 20th century...
Cellular Injury V: Apoptosis and Autophagy01:22

Cellular Injury V: Apoptosis and Autophagy

Cells respond to damage and stress through highly coordinated processes that decide whether they survive or undergo controlled self-destruction. Two major pathways involved in this regulation are apoptosis, a type of programmed cell death, and autophagy, a survival mechanism that helps cells adapt to adverse conditions.ApoptosisApoptosis removes aged or injured cells to maintain tissue balance. During this process, the cell shrinks, chromatin condenses and fragments, and membrane-bound...
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size reduction of the tissue.